Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy Individuals
Evangelos Terpos(National and Kapodistrian University of Athens), Meletios Α. Dimopoulos(National and Kapodistrian University of Athens), Sentiljana Gumeni(National and Kapodistrian University of Athens), Ioannis Ntanasis‐Stathopoulos(National and Kapodistrian University of Athens), Ioannis P. Trougakos(National and Kapodistrian University of Athens), Eleni‐Dimitra Papanagnou(National and Kapodistrian University of Athens), Panagiotis Malandrakis(National and Kapodistrian University of Athens), Vangelis Karalis(National and Kapodistrian University of Athens), Maria Gavriatopoulou(National and Kapodistrian University of Athens), Efstathios Kastritis(AOL (United States))
Cited by 28
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Hematological findings and complications of <scp>COVID</scp>‐19
|American Journal of Hematology|2020|1.7k